maintenance therapy

Type: Keyphrase
Name: maintenance therapy
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

E-Cigarettes and Maintenance Therapy: A Smart Public Health Approach

Martina Paraninfi viaI don't smoke, but I find myself fascinated by and passionate about the debate over e-cigarettes. Why? Because e-cigarettes illustrate how harm reduction approaches to drug policy, particularly maintenance or substitution therapies, ... [Published Huffington Post - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

"NO ONE SHOULD HAVE TO...

– World Lymphoma Awareness DayWilna van den Heever thought she was in the clear after two years of being lymphoma -free, but five years later, she was faced with the same diagnosis. She had relapsed and the cancer had come back with a vengeance.  Despite ... [Published Spice4Life - Sep 16 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Routine Use of Maintenance Therapy in Follicular Lymphoma: Examine the Rationale for Maintenance Use Before Uniformly Adopting a Strategy

1. Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010;116:e90-8.2. Swenson WT, Wooldridge JE, ... [Published Cancernetwork.com - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 2 reports

Findings on Cancer Gene Therapy Reported by Investigators at University College London (Maintenance therapy in ovarian cancer)

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Current study results on Biotechnology have been published. According to news originating from London, United Kingdom, by NewsRx ... ... [Published Wall Street Business Network - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 2 reports

Optimal Strategy in Early Multiple Myeloma: Melphalan, Transplantation, Maintenance

The optimal treatment strategy for patients with newly diagnosed multiple myeloma is consolidation therapy with high-dose melphalan plus stem-cell transplantation, followed by maintenance therapy with lenalidomide, according to the results of a phase ... [Published Cancernetwork.com - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failureFDA approves use of Menactra for booster vaccination against meningococcal diseaseCholera against cholera: an interview with Dr Bruce Turnbull, University of LeedsMetabolic ... [Published News-Medical.Net - Sep 09 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Hope for long-term heroin addiction

A LANDMARK Australian study on heroin addiction shows there’s still hope for a cure even after a decade of maintenance therapy. ... [article truncated...] (Please login or signup to continue reading) ... [Published Medical Observer - Sep 09 2014]
First reported Sep 07 2014 - Updated Sep 07 2014 - 1 reports

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

First reported Sep 04 2014 - Updated Sep 04 2014 - 2 reports

New myeloma treatment options show promise

(HealthDay)—New multiple myeloma treatment options appear promising for patients aged 65 years and younger and for newly diagnosed patients who are ineligible for stem-cell transplantation, according to two studies published in the Sept. 4 issue of the ... [Published Medical Xpress - Sep 04 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 1 reports

Newer Drug Helps Myeloma Patients Who Can't Have Transplant

By Amy NortonHealthDay ReporterWEDNESDAY, Sept. 3, 2014 (HealthDay News) -- A cancer drug that targets the immune system may help improve the outlook for older adults with multiple myeloma, though a stem cell transplant remains the standard of care for ... [Published US News & World Report - Sep 03 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

High-dose chemotherapy plus autologous stem-cell transplantation, as compared with conventional chemotherapy, prolongs progression-free survival and overall survival among patients with newly diagnosed multiple myeloma.– and it is currently the standard ... [Published The New England Journal of Medicine: Hematology ... - Sep 04 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Treatment Evolution after COPD Diagnosis in the UK Primary Care Setting

by Keele E. Wurst, Yogesh Suresh Punekar, Amit ShuklaRationaleTo assess the treatment progression during the 24 months following a formal diagnosis of chronic obstructive pulmonary disease (COPD) in the UK primary care setting.MethodsA retrospective cohort ... [Published Plosone.org - Sep 03 2014]

Quotes

At that two week follow up visit, Hebert recorded pinker tissue with firmer consistency. "The most exciting part for me," she stated, "was that the patient said that his mouth felt better. To me, this was real success. He had taken an active role in his health and changed his homecare." I asked him to return again in two weeks and to continue to use his Trays...
...M D , Director of the Center for Anxiety and Depression in Mercer Island, WA, and Professor Emeritus at the University of Washington in Seattle. "The publication of these findings is an important validation for the sustained efficacy of NeuroStar TMS Therapy in a majority of patients with depression who have not found relief through antidepressant medication."
Dr. Jan-Anders Karlsson , CEO of Verona Pharma commented: "We are pleased with the progress made during the period in our lead drug development programme, RPL554, and the opportunities for its further development and commercialisation. The financing raised in March 2014 enables us to advance the new commercially-scalable proprietary formulation for the product, through clinical studies up to the start of Phase 2b, which is expected in 2016. Our initial focus remains to develop the drug for hospital use in the treatment of acute exacerbations of COPD, where reducing re-admission rates is an emerging pharmacoeconomic impetus."
"There have been relatively few deaths (RR, 11; MR, 13)," the researchers wrote, "and there was no difference in (overall survival) between those assigned to RR and those assigned to MR (94% v 94% at five years)."

More Content

All (110) | News (89) | Reports (0) | Blogs (19) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
We Wanted More for Our Patients - Orkos Award f... [Published Industrial Info Financials - Sep 19 2014]
New Rapidly Acting Technique Could Be Substanti... [Published Psychiatric News - Sep 19 2014]
As-needed rituximab controlled follicular lymph... [Published Orthopedics Today - Sep 18 2014]
E-Cigarettes and Maintenance Therapy: A Smart P... [Published Huffington Post - Sep 17 2014]
National Osteoporosis Society Vitamin D Guideli... [Published General Medicine eJournal - Sep 17 2014]
Journal of Clinical Psychiatry: Long-term Benef... [Published ScienceNewsline - Sep 17 2014]
"NO ONE SHOULD HAVE TO... [Published Spice4Life - Sep 16 2014]
Folliculitis facts [Published The News International - Sep 16 2014]
NEJM and ERS publish positive results from GSK ... [Published Drugs.com - Sep 16 2014]
Routine Use of Maintenance Therapy in Follicula... [Published Cancernetwork.com - Sep 15 2014]
Beyond the Clinical Trial [Published OncLive - Sep 14 2014]
Bleach-based gel wash improves severity of atop... [Published Dermatology Times - Sep 13 2014]
VERONA PHARMA : Interim results for the six mon... [Published 4 Traders - Sep 12 2014]
Mental health: Primary care lithium monitoring [Published GP Online - Sep 12 2014]
Follicular Lymphomas: Continuous Rituximab May ... [Published American Journal of Public Health - Sep 12 2014]
Boehringer Ingelheim's Phase III COPD studies m... [Published Individual.com - Sep 11 2014]
Mologen AG enrolls first patient in internation... [Published Reuters - Sep 11 2014]
Kidney transplant for cats can be done [Published Examiner.com - Sep 11 2014]
Findings on Cancer Gene Therapy Reported by Inv... [Published Wall Street Business Network - Sep 10 2014]
Findings on Cancer Gene Therapy Reported by Inv... [Published HispanicBusiness.com - Sep 10 2014]
Optimal Strategy in Early Multiple Myeloma: Mel... [Published Cancernetwork.com - Sep 10 2014]
Monoclonal Antibody Therapy for Relapsed or Tre... [Published National Cancer Institute - Sep 10 2014]
Autologous Transplantation and Maintenance Ther... [Published NEJM Most Viewed Articles - Week - Sep 10 2014]
Asthma Drug Mepolizumab Shows Promise in Phase ... [Published PT Community - Sep 09 2014]
TESARO Seeks FDA Approval for NK-1 Receptor Rol... [Published Zacks.com - Sep 09 2014]
Teva Pharmaceuticals New Drug Aims to Reduce As... [Published Motley Fool Discussion Boards - Sep 09 2014]
Inspire Malibu Redefines Addiction Treatment Wi... [Published PRWeb - Sep 09 2014]
Withdrawal of Inhaled Glucocorticoids and Exace... [Published New England Journal of Medicine - Sep 09 2014]
Hope for long-term heroin addiction [Published Medical Observer - Sep 09 2014]
New data from Boehringer's Phase III trial prog... [Published News-Medical.Net - Sep 09 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Autologous Transplantation and Maintenance Ther... [Published NEJM Most Viewed Articles - Week - Sep 10 2014]
Autologous Transplantation and Maintenance Ther... [Published NEJM Most Emailed Articles - Sep 07 2014]
Propeller Health raises $14.5M for GPS asthma i... [Published Venturebeat - Sep 04 2014]
Above: Propeller Health's device attaches to the end of an inhaler. Image Credit: Propeller Health Asthma and chronic obstructive pulmonary disease (COPD) currently cost payers and patients in the United States over $100 billion annually. By 2020, ...
Propeller Health fetches $14.5 mln Series B [Published PE Hub Blog - Sep 04 2014]
Propeller Health said Thursday that it has closed $14.5 million in Series B funding. Safeguard Scientifics led the round with participation from return backer The Social+Capital Partnership . Also, the firm has hired Chris Hogg as COO. Propeller ...
Autologous Transplantation and Maintenance Ther... [Published The New England Journal of Medicine: Hematology ... - Sep 04 2014]
High-dose chemotherapy plus autologous stem-cell transplantation, as compared with conventional chemotherapy, prolongs progression-free survival and overall survival among patients with newly diagnosed multiple myeloma.– and it is currently the standard ...
1 2 3 4

Press Releases

sort by: Date | Relevance
Genmab Announces Financial Results for the Firs... [Published GlobeNewswire: Acquisitions News - Aug 13 2014]
Positive Top-line Results from Two Phase 3 Clin... [Published GlobeNewswire: Advertising News - Jun 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.